Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Addus HomeCare Stock Up 0.9 %
Shares of NASDAQ:ADUS opened at $122.00 on Friday. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12. The business has a fifty day moving average of $125.67 and a two-hundred day moving average of $124.28. The stock has a market cap of $2.21 billion, a P/E ratio of 27.92, a PEG ratio of 2.11 and a beta of 1.01.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business earned $1.03 earnings per share. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Institutional Trading of Addus HomeCare
Analysts Set New Price Targets
Several equities analysts recently weighed in on ADUS shares. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Wednesday. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.
Read Our Latest Analysis on Addus HomeCare
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
- Five stocks we like better than Addus HomeCare
- Election Stocks: How Elections Affect the Stock Market
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- What Does a Stock Split Mean?
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Why Invest in High-Yield Dividend Stocks?
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.